β2-glycoprotein I is a cofactor for tissue plasminogen activator-mediated plasminogen activation

Arthritis and Rheumatism

Volumn 60, Issue 2, 2009, Pages 559-568

  Bu, Chunya ^a   Gao, Lei ^a   Xie, Weidong ^a   Zhang, Jainwei ^b   He, Yuhong ^a   Cai, Guoping ^a   McCrae, Keith R ^b  

^a TSINGHUA UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN G; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; ANTICOAGULANT AGENT; BLOCKING ANTIBODY; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; RECOMBINANT PROTEIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOT LYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRINOLYSIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FOLDING; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CLONING, MOLECULAR; FIBRINOLYSIS; HUMANS; PLASMINOGEN; PROTEIN BINDING; RECOMBINANT PROTEINS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 59649088830     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24262     Document Type: Article

References (36)

1. 2-glycoprotein I to human serum lipoproteins. FEBS Lett 1979;102:183-6.
2. 2-glycoprotein I. Proc Natl Acad Sci U S A 1984;81:3640-4.
3. Kamboh MI, Mehdi H. Genetics of apolipoprotein H (β2-glycoprotein I) and anionic phospholipid binding. Lupus 1998;7 Suppl 2:S10-3.
4. Ohkura N, Hagihara Y, Yoshimura T, Goto Y, Kato H. Plasmin can reduce the function of human β2 glycoprotein I by cleaving domain V into a nicked form. Blood 1998;91:4173-9.
5. Galli M. Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol Haemost Thromb 2003;33:249-55.
6. Lutters BC, De Groot PG, Derksen RH. β2 Glycoprotein I - a key player in the antiphospholipid syndrome. Isr Med Assoc J 2002;4:958-62.
7. Miyakis S, Giannakopoulos B, Krilis SA. β2 glycoprotein I - function in health and disease. Thromb Res 2004;114:335-46.
8. 2- glycoprotein I. Biochim Biophys Acta 1986;884:142-9.
9. Ieko M, Ichikawa K, Triplett DA, Matsuura E, Atsumi T, Sawada K, et al. β2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum 1999;42:167-74.
10. Sheng Y, Reddel SW, Herzog H, Wang YX, Brighton P, France MP, et al. Impaired thrombin generation in β2 glycoprotein I null mice. J Biol Chem 2001;276:13817-21.
11. Takeuchi R, Atsumi T, Ieko M, Ichikawa K, Koike T. Suppressed intrinsic fibrinolytic activity by monoclonal anti β2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome. Br J Haematol 2002;119:781-8.
12. Ieko M, Ichikawa K, Atsumi T, Takeuchi R, Sawada KI, Yasukouchi T, et al. Effects of β2 glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis. Semin Thromb Hemost 2000;26:85-90.
13. Dobrovolsky AB, Titaeva EV. The fibrinolysis system: regulation of activity and physiologic functions of its main components. Biochemistry 2002;67:99-108.
14. Stack S, Cronow M, Pizzo SV. Regulation of plasminogen activation by components of the extracellular matrix. Biochemistry 1990;29:4966-70.
15. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982;257:2912-9.
16. Hajjar K, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994;269:21191-7.
17. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994;269:21198-203.
18. Kassam G, Choi KS, Ghuman J, Kang HM, Fitzpatrick SL, Zackson T, et al. The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 1998;273:4790-9.
19. Roda O, Valero ML, Peiro S, Andreu D, Real FX, Nawroth P. New insights into the t-PA annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association? J Biol Chem 2003;278:5702-9.
20. Cesarman MG, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol 2005;129:307-21.
21. Lopez-Lira F, Rosales LL, Monroy MV, Ruiz OB. The role of β2 glycoprotein I (β2 GPI) in the activation of plasminogen. Biochim Biophys Acta 2006;1764:815-23.
22. Yasuda S, Atsumi T, Ieko M, Matsuura E, Kobayashi K, Inagaki J, et al. Nicked β2 glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis. Blood 2004;103:3766-72.
23. Cai G, Guo Y, Shi J. Purification of apolipoprotein H by polyethylene glycol precipitation. Protein Expr Purif 1996;8:341-6.
24. 2- glycoprotein I cDNA. FEBS Lett 1991;289:183-6.
25. Goding J. Monoclonal antibodies: principles and practice. 2nd ed. London: Academic Press; 1986.
26. Nagashima M, Yin ZF, Zhao L, White K, Zhu Y, Lasky N, et al. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. J Clin Invest 2001;109:101-10.
27. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
28. 2 glycoprotein antibodies. Blood 2005;105:1964-9.
29. Cugno M, Cabbibe M, Galli M, Meroni PL, Caccia S, Russo R, et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in two patients. Blood 2004;103:2121-6.
30. Machovich R, Owen WG. Denatured proteins as cofactors for plasminogen activation. Arch Biochem Biophys 1997;344:343-9.
31. MacLeod TJ, Kwon M, Filipenko NR, Waisman DA. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits. J Biol Chem 2003;278:25577-84.
32. Cesarman-Maus G, Rios-Luna N, Deora AB, Huang B, Villa R, del Carmen Cravioto M, et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 2006;107:4375-82.
33. 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 2000;275:15541-8.
34. Van Lummel M, Pennings MT, Derksen RH, Urbanus RT, Lutters BC, Kaldenholven N, et al. The binding site in β2 glycoprotein I for ApoER2′ on platelets is located in domain V. J Biol Chem 2005;280:36729-36.
35. Shi T, Iverson GM, Qi JC, Cockerill KA, Linnik MD, Konecny P, et al. β2-glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped β2 glycoprotein I. Proc Natl Acad Sci U S A 2004;101:3939-44.
36. 2-glycoprotein I mediated by the kringle IV domain. Blood 1997;90:1482-9.